These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20647862)

  • 21. Left ventricular hypertrophy induced by overnutrition early in life.
    Moreira AS; Teixeira Teixeira M; da Silveira Osso F; Pereira RO; de Oliveira Silva-Junior G; Garcia de Souza EP; Mandarim de Lacerda CA; Moura AS
    Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):805-10. PubMed ID: 19359151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalent influence of systolic over pulse pressure on left ventricular mass in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Gattobigio R; Ambrosio G; Porcellati C
    Eur Heart J; 2002 Apr; 23(8):658-65. PubMed ID: 11969281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low mid-wall fractional shortening identifies a subgroup of hypertensive patients with increased left ventricular mass and ambulatory blood pressure.
    Porcellati C; Verdecchia P; Schillaci G; Zampi I; Battistelli M; Bartoccini C; Borgioni C; Ciucci A; Boschetti E
    J Hypertens Suppl; 1993 Dec; 11(5):S102-3. PubMed ID: 8158295
    [No Abstract]   [Full Text] [Related]  

  • 24. Left atrial size in children with hypertension: the influence of obesity, blood pressure, and left ventricular mass.
    Daniels SR; Witt SA; Glascock B; Khoury PR; Kimball TR
    J Pediatr; 2002 Aug; 141(2):186-90. PubMed ID: 12183712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ambulatory blood pressure monitoring assessment of blood pressure control in hypertension associated with chronic renal failure.
    Morduchowicz G; Zabludowski J; Wittenberg C; Winkler J; Boner G
    Nephrol Dial Transplant; 1993; 8(10):1169-71. PubMed ID: 8272233
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular manifestations of autosomal dominant polycystic kidney disease in young adults.
    Handa SP
    Clin Invest Med; 2006 Dec; 29(6):339-46. PubMed ID: 17330449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity-related cardiac and vascular structural alterations: beyond blood pressure overload.
    Grassi G; Diez J
    J Hypertens; 2009 Sep; 27(9):1750-2. PubMed ID: 19692848
    [No Abstract]   [Full Text] [Related]  

  • 28. How to best assess blood pressure? The ongoing debate on the clinical value of blood pressure average and variability.
    Stergiou GS; Parati G
    Hypertension; 2011 Jun; 57(6):1041-2. PubMed ID: 21536987
    [No Abstract]   [Full Text] [Related]  

  • 29. Twenty-four-hour heart rate and blood pressure are additive markers of left ventricular mass in hypertensive subjects.
    Zakopoulos NA; Ikonomidis I; Vemmos KN; Manios E; Spiliopoulou I; Tsivgoulis G; Spengos K; Psaltopoulou D; Mavrikakis M; Moulopoulos SD
    Am J Hypertens; 2006 Feb; 19(2):170-7. PubMed ID: 16448887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ventricular hypertrophy as an expression of hypertensive damage].
    Chiariello M; Betocchi S
    Cardiologia; 1991 Dec; 36(12 Suppl 1):79-84. PubMed ID: 1841809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ambulatory blood pressure monitoring and target organ damage in pediatrics.
    Stabouli S; Kotsis V; Zakopoulos N
    J Hypertens; 2007 Oct; 25(10):1979-86. PubMed ID: 17885534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?
    Verdecchia P; Angeli F; Gattobigio R; Guerrieri M; Benemio G; Porcellati C
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S23-8. PubMed ID: 15592569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epicardial coronary vessels and coronary microcirculation in pressure overload hypertrophy: a complex interaction.
    Galderisi M
    Am J Hypertens; 2007 Mar; 20(3):285-6. PubMed ID: 17324741
    [No Abstract]   [Full Text] [Related]  

  • 34. Twenty-four-hour mean heart rate and likelihood of left ventricular hypertrophy.
    Palmieri V
    Am J Hypertens; 2006 Feb; 19(2):178. PubMed ID: 16448888
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cardiovascular risk and the measurement of arterial pressure].
    Vaisse B; Silhol F; Bouchlagem K; Maximovitch A; Poggi L
    Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():9-12. PubMed ID: 9805563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular morphology and diastolic function in severe obesity: current views.
    Alpert MA; Chan EJ
    Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):1-3. PubMed ID: 22036240
    [No Abstract]   [Full Text] [Related]  

  • 37. Preclinical effects of healthy obesity on inappropriate left ventricular mass and systolic function.
    Paneni F; Gregori M; Marra A; Passerini J; Santolamazza C; Befani A; Ciavarella GM; Magrì D; Tocci G; Ferrucci A; Volpe M
    Int J Cardiol; 2013 Sep; 167(6):3047-9. PubMed ID: 23232457
    [No Abstract]   [Full Text] [Related]  

  • 38. Left Ventricular Hypertrophy in Hypertension and Nocturnal Blood Pressure.
    Bursztyn M
    J Clin Hypertens (Greenwich); 2015 Dec; 17(12):914-5. PubMed ID: 26176341
    [No Abstract]   [Full Text] [Related]  

  • 39. Ambulatory monitoring and clinic BP measurements for predicting left ventricular mass in patients with chronic renal diseases.
    Zoccali C; Tripepi G
    Nephrol Dial Transplant; 1999 Jan; 14(1):240-1. PubMed ID: 10052521
    [No Abstract]   [Full Text] [Related]  

  • 40. Surrogate end points in clinical trials.
    Man in 't Veld AJ
    Blood Press Suppl; 1997; 2():120-3. PubMed ID: 9495640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.